BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6509461)

  • 1. Indapamide, a new antihypertensive/diuretic agent, in the treatment of patients with edema.
    Eff J; Bratnick J; Zisblatt M; Vukovich RA; Neiss E
    Clin Ther; 1984; 6(6):778-86. PubMed ID: 6509461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy and safety of indapamide in the treatment of edema.
    Slotkoff L
    Am Heart J; 1983 Jul; 106(1 Pt 2):233-7. PubMed ID: 6869205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension.
    Luccioni R; Sever PS; Di Perri T; Redon J; Laurandin I; Brault Y; Chastang C; Guez D
    J Hypertens; 1995 Dec; 13(12 Pt 2):1847-51. PubMed ID: 8903665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA; Rizzoni D;
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
    Gleim GW; Rubino J; Zhang H; Shahinfar S; Soffer BA; Lyle PA; Littlejohn TW; Feig PU
    Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic benefit of a low dose of indapamide: results of a double-blind against placebo European controlled study].
    Asmar R; Guez D; Malbezin M; Brault Y; de Cordoue A; Barrandon S; Bruxelles MC; Chastang C
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1083-7. PubMed ID: 8572850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perindopril + indapamide: new preparation. Simple trick.
    Prescrire Int; 1999 Dec; 8(44):172-5. PubMed ID: 11503814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison.
    Spence JD; Huff M; Barnett PA
    Can J Clin Pharmacol; 2000; 7(1):32-7. PubMed ID: 10822211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indapamide: clinical pharmacology, therapeutic efficacy in hypertension, and adverse effects.
    Mroczek WJ
    Pharmacotherapy; 1983; 3(2 Pt 1):61-7. PubMed ID: 6856486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indapamide in the treatment of essential arterial hypertension in the elderly.
    Van Hee W; Thomas J; Brems H
    Postgrad Med J; 1981; 57 Suppl 2():29-33. PubMed ID: 7033944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments.
    Giusti A; Barone A; Pioli G; Girasole G; Siccardi V; Palummeri E; Bianchi G
    Nephrol Dial Transplant; 2009 May; 24(5):1472-7. PubMed ID: 19075192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a fixed-dose ACE inhibitor-diuretic combination on ambulatory blood pressure and arterial properties in isolated systolic hypertension.
    Ferguson JM; Minas J; Siapantas S; Komesaroff PA; Sudhir K
    J Cardiovasc Pharmacol; 2008 Jun; 51(6):590-5. PubMed ID: 18520951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of hypertension with indapamide 1.5 mg sustained-release form: synthesis of results].
    Guez D; Mallion JM; Degaute JP; Malini PL; Baldwin R; Rodriguez-Pujol D; de Cordoüe A; Barrandon S; Chastang C; Safar M
    Arch Mal Coeur Vaiss; 1996 Sep; 89 Spec No 4():17-25. PubMed ID: 8952810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indapamide (Lozol)--a new antihypertensive agent and diuretic.
    Med Lett Drugs Ther; 1984 Feb; 26(655):17-8. PubMed ID: 6363897
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study.
    Holzgreve H; Risler T; Trenkwalder P
    Curr Med Res Opin; 2006 Sep; 22(9):1849-58. PubMed ID: 16968588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the efficacy of indapamide and bendrofluazide given in combination with atenolol.
    Zacharias FJ
    Postgrad Med J; 1981; 57 Suppl 2():51-2. PubMed ID: 7033947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower dose diuretic therapy in the treatment of patients with mild to moderate hypertension.
    Hall WD; Weber MA; Ferdinand K; Flamenbaum W; Marbury T; Jain AK; Weidler D; Weiss R; Herron J; Codispoti J
    J Hum Hypertens; 1994 Aug; 8(8):571-5. PubMed ID: 7990083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.